Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Table 1.

Descriptive characteristics of the study population by HIV status.

More »

Table 1 Expand

Table 2.

Number of people with available data and crude prevalence (%) of cardiovascular disease (CVD) risk factors and of risk of CVD by population.

More »

Table 2 Expand

Fig 1.

Adjusted odds ratio (OR) and 95% confidence interval (95% CI) of cardiovascular (CVD) risk factors and total CVD risk comparing HIV-infected adults to the general population.

Model 1: adjusted for age, sex and country of origin; Model 2: Model 1 plus additional adjustment for HBsAg(+) or anti-HCV(+) and educational level; Model 3: Model 2 plus additional adjustment for body mass index (BMI). Ten-year risk of fatal and non-fatal CVD using the Framingham risk score (FRS) was calculated for the individuals >20 years whereas 10-year risk of fatal CVD using the Systematic Coronary Risk Evaluation (SCORE) for the non-diabetic individuals >20 years. FRS risk ≥20% or SCORE risk score ≥5% were considered as high risk.

More »

Fig 1 Expand

Table 3.

Predicted marginal prevalence (for the model that adjusts for age, sex and origin) and 95% confidence interval (CI) of comorbidities and risk factors by HIV status.

More »

Table 3 Expand

Table 4.

Adjusted odds ratio (OR) and 95% confidence interval (95% CI) of cardiovascular (CVD) risk factors and total CVD risk, comparing HIV-infected to the general population.

More »

Table 4 Expand